This study assesses mass Zithromax administration coverage, social mobilization and campaign challenges in south and southeast zones of Tigray, Ethiopia.
This coverage survey was conducted as part of an ongoing monitoring strategy within the Amhara Trachoma Control Program. The Carter Center provided the Amhara Regional Health Bureau with support to implement MDA, and separately, also funded, designed and executed this survey in collaboration with the Regional Health Bureau.
Data from this study suggests that antibody responses could be useful indicators for post-validation surveillance.
Originally posted in Community Eye Health Journal Vol.30 No.99.
The WHO recommends 3–5 years of annual mass azithromycin distribution with at least 80% treatment coverage to districts with active trachoma prevalence over 10% among children. This article assesses the efficacy of expanding the coverage target to at least 90% for trachoma control in a mesoendemic region of Niger.
This trial was designed to determine if a surveillance program that targeted newcomers and travellers would result in more communities achieving levels of infection of ≤1%.
In South Sudan, five counties in Eastern Equatoria state were surveyed to monitor the progress of programmatic interventions and determine if additional rounds of Mass Drug Administration with azithromycin were needed to reduce trachoma.
Ce manuel constitue une lecture essentielle pour l’ensemble des responsables de programmes, des partenaires de mise en oeuvre, des agents d’exécution et des étudiants qui aspirent à maximiser l’efficacité de leurs programmes d’administration massive de médicaments (AMM).